Vimarsana
Biggest News Aggregation in the World

Page 7 - Kent Alpha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kent Alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kent Alpha Today - Breaking & Trending Today

Dow drops 350 points after Moderna CEO warns it will take MONTHS to develop Omicron vaccine - Vimarsana News

Dow drops 350 points after Moderna CEO warns it will take MONTHS to develop Omicron vaccine

U.S. stocks opened sharply lower on Tuesday after a warning from vaccine maker Moderna's CEO that COVID-19 shots could be less effective against Omicron variant.

Omicron variant is unlikely to cause severe illness in vaccinated people, BioNTech says - Vimarsana News

Omicron variant is unlikely to cause severe illness in vaccinated people, BioNTech says

The co-founder of the biotechnology company BioNTech believes that people fully vaccinated with his company's vaccine, a joint project with Pfizer, are safe from severe Omicron infection.

Experts say it is too early to worry about the Omicron variant in the US - Vimarsana News

Experts say it is too early to worry about the Omicron variant in the US

Experts say that it is too early for someone to worry about the Omicron variant, but people should still take precautions to protect themselves from Covid, and especially the ever-present Delta variant.

New York is ALREADY seeing signs of winter COVID-19 spike - Vimarsana News

New York is ALREADY seeing signs of winter COVID-19 spike

Although holiday travel and gatherings have just started and colder days lay ahead, the city just recorded a spike of 2.22percent in COVID-19 cases - the highest in two months.

Moderna CEO warns vaccine antibody levels could be up to EIGHT TIMES lower against Omicron variant - Vimarsana News

Moderna CEO warns vaccine antibody levels could be up to EIGHT TIMES lower against Omicron variant

Moderna CEO Stephane Bancel told CNBC that his company's COVID-19 vaccine may be less effective against the Omicron variant than it is others, though they could update the vaccine.